Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 (Healthy Volunteers)”

242 trials

Showing 20 of 242 results

Not applicableUnknownNCT04547114
What this trial is testing

Breath Analysis for SARS-CoV-2 in Infected and Healthy Subjects

Who this might be right for
SARS-CoV-2 Infection
Klinikum Bayreuth GmbH 200
Early research (Phase 1)Ended earlyNCT05280717
What this trial is testing

Relative Bioavailability, Safety, and Tolerability of Single-dose Sotrovimab Injection in Adults (COSMIC)

Who this might be right for
Covid19
Vir Biotechnology, Inc. 316
Early research (Phase 1)Looking for participantsNCT07093580
What this trial is testing

Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants

Who this might be right for
Healthy Participants
Shionogi 98
Early research (Phase 1)Study completedNCT05017168
What this trial is testing

To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P63 in Healthy Subjects

Who this might be right for
SARS-CoV-2 Infection
Celltrion 24
Early research (Phase 1)Study completedNCT04737486
What this trial is testing

A First-in-Human Study of AV-001 in Healthy Subjects

Who this might be right for
Covid19-associated ARDSCovid19ARDS
Vasomune Therapeutics, Inc. 48
Early research (Phase 1)Study completedNCT05148962
What this trial is testing

Study of GRT-R910 COVID-19 Boost Vaccine in Healthy Volunteers

Who this might be right for
COVID-19
Gritstone bio, Inc. 45
Testing effectiveness (Phase 2)Study completedNCT04930003
What this trial is testing

Reactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 Vaccine

Who this might be right for
Covid19SARS-CoV InfectionVaccine Adverse Reaction
Research Institute for Biological Safety Problems 244
Testing effectiveness (Phase 2)Study completedNCT05142514
What this trial is testing

Safety and Immunogenicity of Recombinant Protein RBD Fusion Dimer Vaccine Against the Virus That Cause COVID-19, Known as Severe Acute Respiratoy Syndrome Coronavirus 2 (SARS-CoV-2)

Who this might be right for
COVID-19SARS-CoV-2 Acute Respiratory Disease
Hipra Scientific, S.L.U 629
Early research (Phase 1)Study completedNCT04497298
What this trial is testing

Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine

Who this might be right for
COVID-19
Institut Pasteur 90
Early research (Phase 1)Study completedNCT05298787
What this trial is testing

SAD/MAD Study of RLS-0071 in Healthy Volunteers in Support of a COVID-19 Development Program

Who this might be right for
Healthy Volunteer
ReAlta Life Sciences, Inc. 56
Early research (Phase 1)Study completedNCT05208996
What this trial is testing

The siCoV/KK46 Drug Open-safety Study

Who this might be right for
COVID-19
National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia 10
Early research (Phase 1)Study completedNCT05011812
What this trial is testing

Study of PBI-0451 in Healthy Subjects.

Who this might be right for
Covid19
Pardes Biosciences, Inc. 130
Testing effectiveness (Phase 2)Study completedNCT05904054
What this trial is testing

Immunogenicity and Safety Study of SARS-CoV-2 DNA Vaccine (ICCOV)

Who this might be right for
COVID-19
Immuno Cure 3 Limited 31
Early research (Phase 1)Study completedNCT04877769
What this trial is testing

Bronchopulmonary PK of AT-527 (R07496998)

Who this might be right for
Healthy Volunteer Study
Atea Pharmaceuticals, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT05519839
What this trial is testing

Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine

Who this might be right for
COVID-19Influenza
Novavax 1,579
Early research (Phase 1)Ended earlyNCT04627675
What this trial is testing

CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2)

Who this might be right for
SARS-CoV-2
Providence Health & Services 16
Early research (Phase 1)Study completedNCT05685719
What this trial is testing

Evaluate the Relative Bioavailability of STI-1558 and the Effect of Itraconazole and Rifampin on the Pharmacokinetics of STI-1558

Who this might be right for
COVID-19 Pneumonia
Zhejiang ACEA Pharmaceutical Co. Ltd. 37
Not applicableStudy completedNCT05311865
What this trial is testing

Transmission of Covid-19 During Clubbing Events in Closed Places

Who this might be right for
Healthy Participant
ANRS, Emerging Infectious Diseases 1,216
Early research (Phase 1)Study completedNCT05677893
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled MBS-COV (SNS812) in Healthy Participants

Who this might be right for
Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder)
Oneness Biotech Co., Ltd. 44
Early research (Phase 1)Study completedNCT04962022
What this trial is testing

Drug-Drug Interaction Study Assessing Effect of Itraconazole on PF-07321332/Ritonavir in Healthy Participants

Who this might be right for
Healthy Participant
Pfizer 12
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation